Boswellia serrata is a medicinal plant whose active compounds, particularly boswellic acids, have been extensively studied for their anti-inflammatory and joint-support properties. Today, it is recognized as one of the main physiopathological mechanisms involved in the development of numerous chronic degenerative conditions. Unlike acute inflammation, characterized by evident clinical signs, silent inflammation often manifests with nonspecific or subclinical symptoms, such as persistent fatigue, gastrointestinal disorders, fluid retention, widespread muscle pain, and alterations in general well-being.
Scientific evidence shows how this persistent inflammatory state is correlated with metabolic dysfunctions, alterations in intestinal permeability, oxidative stress, and progressive tissue deterioration. In this context, modern nutraceuticals offer integrated strategies based on phytocomplexes and bioactive substances capable of modulating the main pathways of inflammation and oxidative stress.
MOLTITUDO® LUNAE was created with this physiological rationale: to combine bromelain, Boswellia serrata, and tetrahydrocurcuminoids in a multi-target formulation designed to support joint function, gastrointestinal well-being, fluid drainage, and microcirculation.
PRODUCT_ITEM
It is recommended to take 1 tablet daily, with water, preferably with meals.
In case of greater need, it is possible to take 2 tablets daily, divided into two doses with meals
Do not exceed the recommended daily dose.
The maximum daily dose of 2 tablets provides:
|
Ingredient |
Quantity |
Standardization |
|
Bromelain |
1000 mg |
2500 GDU |
|
Boswellia serrata e.s. |
500 mg |
65% boswellic acids |
|
Tetrahydrocurcuminoids |
140 mg |
≥95% |
The formulation was designed to act simultaneously on:
- inflammatory mediators;
- edema and tissue permeability;
- oxidative stress;
- gastrointestinal function;
- joint and muscle comfort.
Bromelain: proteolytic enzyme with anti-edema and anti-inflammatory activity
What is bromelain
Bromelain is a complex of proteolytic enzymes extracted from Ananas comosus. In addition to its traditional digestive activity, bromelain is now widely studied for its anti-inflammatory, fibrinolytic, and anti-edema properties.
Mechanisms of action
The main biological activities include:
- modulation of capillary permeability;
- fibrin degradation;
- interference with prostaglandins and bradykinin;
- regulation of pro-inflammatory cytokines;
- support of interstitial fluid drainage.
From a physiological point of view, bromelain acts on the inflammatory response without completely blocking biological pathways, contributing to a more balanced modulation of inflammation.
Clinical evidence
Several clinical studies have documented benefits in controlling post-traumatic edema, joint pain, and soft tissue inflammation.
One study published in QJM highlighted a significant reduction in mild acute knee pain after bromelain supplementation. Furthermore, recent systematic reviews confirm the usefulness of bromelain in controlling post-operative edema and pain in oral surgery.
Maurer HR. Cell Mol Life Sci. 2001.
Walker AF et al. QJM. 2002.
de Souza GM et al. Phytother Res. 2019.
Varilla V et al. Evid Based Complement Alternat Med. 2021.
Boswellia serrata: 5-lipoxygenase modulation and joint support
Boswellic acids and inflammation
Boswellia serrata is a resin traditionally used in Ayurvedic medicine for the treatment of inflammatory conditions.
The main active compounds are boswellic acids, in particular AKBA (acetyl-11-keto-β-boswellic acid), known for its inhibitory activity on 5-lipoxygenase (5-LOX), a key enzyme in the synthesis of pro-inflammatory leukotrienes.
Physiological mechanisms
Boswellia acts through:
- inhibition of 5-LOX;
- modulation of NF-κB;
- reduction of TNF-α, IL-1, IL-6;
- protection of articular cartilage;
- support of the intestinal mucosa.
This activity makes Boswellia particularly interesting in contexts characterized by chronic joint inflammation and musculoskeletal discomfort.
Clinical studies
Several clinical trials have shown improvements in pain, joint stiffness, and motor function in subjects with osteoarthritis.
A study published in Phytomedicine highlighted a significant reduction in knee pain after 8 weeks of treatment with Boswellia extract.
Kimmatkar N et al. Phytomedicine. 2003.
Sengupta K et al. Int J Med Sci. 2010.
Ammon HP. Planta Med. 2006.
Tetrahydrocurcuminoids: technological evolution of curcumin
Why use tetrahydrocurcuminoids
Curcumin has pharmacokinetic limitations related to:
- low solubility;
- rapid glucuronidation;
- reduced oral bioavailability.
To overcome these limitations, MOLTITUDO® LUNAE uses tetrahydrocurcuminoids (THC), reduced active metabolites of curcumin characterized by:
- greater stability;
- better functional bioavailability;
- superior antioxidant activity;
- better gastrointestinal tolerance.
Biological activities
Tetrahydrocurcuminoids contribute to:
- modulating NF-κB;
- reducing oxidative stress;
- protecting cell membranes;
- supporting redox balance;
- supporting gastrointestinal well-being.
Scientific evidence
The scientific literature documents the activity of curcumin and its metabolites in modulating inflammatory cytokines, oxidative stress, and intracellular pathways associated with chronic inflammation.
Aggarwal BB et al. Int J Biochem Cell Biol. 2009.
Jurenka JS. Altern Med Rev. 2009.
Panahi Y et al. J Diet Suppl. 2016.
Pan MH et al. Mol Nutr Food Res. 2008.
Okada K et al. Biol Pharm Bull. 2001.
Synergistic action of the formulation
The combination of bromelain, Boswellia, and tetrahydrocurcuminoids allows for an integrated modulation of the main pathways involved in low-grade chronic inflammation.
The main physiological effects include:
Joint support
Boswellia acts on the leukotriene pathway, while tetrahydrocurcuminoids modulate NF-κB and oxidative stress, contributing to joint comfort.
Fluid drainage and microcirculation
Bromelain promotes the reabsorption of interstitial fluids and supports tissue permeability.
Gastrointestinal well-being
Bromelain supports protein digestion, while tetrahydrocurcuminoids contribute to the protection of the intestinal mucosa.
Antioxidant support
THC exerts a marked free-radical scavenging activity, contributing to cellular protection.
Silent chronic inflammation and integrated nutraceuticals
Silent chronic inflammation is today considered one of the main biological drivers of:
- accelerated aging;
- metabolic dysfunctions;
- cardiovascular alterations;
- neurodegenerative disorders;
- chronic joint problems.
In these contexts, the nutraceutical approach can represent a valid complementary support to lifestyle, especially when associated with:
- a balanced diet;
- regular physical activity;
- stress management;
- sleep quality;
- reduction of oxidative load.
MOLTITUDO® LUNAE fits into this scenario as a formulation aimed at the physiological support of inflammatory balance and the general well-being of the body.
Safety and tolerability
The ingredients present in the product show a generally favorable safety profile at the doses commonly used in food supplements.
Possible precautions
Use requires caution in case of:
- anticoagulant or antiplatelet therapies;
- hepato-biliary pathologies;
- gallstones;
- pregnancy and breastfeeding;
- allergy to the components.
Use must occur in compliance with the indications reported on the label and under the advice of the healthcare professional in fragile or poly-medicated subjects.
Conclusions
MOLTITUDO® LUNAE represents a rational nutraceutical formulation based on standardized ingredients with complementary activities documented in scientific literature.
The association between bromelain, Boswellia serrata and tetrahydrocurcuminoids allows a multi-target approach aimed at the physiological support:
- of joint functionality;
- of fluid drainage;
- of gastrointestinal comfort;
- of the response to oxidative stress.
The available evidence suggests a potential role as a complementary support in conditions characterized by low-grade chronic inflammation, joint discomfort and microcirculation alterations, always within the framework of an integrated lifestyle approach.
NOTE: The information present in the product sheets of this site is exclusively for informative and educational purposes and does not represent a medical opinion. The published contents do not intend to replace the relationship with the doctor nor any healthcare indications, diagnoses or prescriptions. The reported information describes the ingredients and characteristics of food supplements, designed as support for the balance and well-being of the body within a healthy lifestyle. Food supplements are not medicines and must not be used to prevent, diagnose, treat or alleviate diseases or pathological conditions.
Essential bibliography
- Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001.
- Walker AF et al. Bromelain reduces mild acute knee pain. QJM. 2002.
- de Souza GM et al. Bromelain in oral surgery. Phytother Res. 2019.
- Varilla V et al. Bromelain anti-inflammatory properties. Evid Based Complement Alternat Med. 2021.
- Kimmatkar N et al. Boswellia serrata in osteoarthritis. Phytomedicine. 2003.
- Sengupta K et al. Boswellia extracts in osteoarthritis. Int J Med Sci. 2010.
- Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006.
- Aggarwal BB et al. Curcumin therapeutic effects. Int J Biochem Cell Biol. 2009.
- Jurenka JS. Anti-inflammatory properties of curcumin. Altern Med Rev. 2009.
- Panahi Y et al. Curcuminoids in osteoarthritis. J Diet Suppl. 2016.
- Pan MH et al. Bioavailability of curcuminoids. Mol Nutr Food Res. 2008.
- Okada K et al. Metabolism of curcumin. Biol Pharm Bull. 2001.
